Bio-tests for Schizophrenia And Depression

Article

The race to patent bio-tests for schizophrenia and depression: some say this initiative is destined to fail.

Recent articles by Arline Kaplan and Hagop Asiskal, MD, highlight the race to patent bio-tests for schizophrenia and depression. Dr Max Fink continues the discussion in his commentary; he contends the DSM divisions serve patients and doctors poorly. Tell us what you think.
 

Related Videos
Experts on MDD.
Experts on MDD.
Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?
© 2023 MJH Life Sciences

All rights reserved.